Skip to main content
Springer Nature Link
Log in

Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The subtype of dopamine (DA) receptors mediating the yawning response to DA agonists was determined in rats. Yawning was elicited both by the mixed D1–D2 agonist apomorphine and by the specific D2 agonist LY 171555, but not by the selective D1 agonist SKF 38393. Both apomorphine- and LY 171555-induced yawning were antagonized not only by the selective D2 antagonist sulpiride but, unexpectedly, also by the selective D1 antagonist SCH 23390. The results suggest that DA receptors mediating the yawning response are of the D2 type, and that these receptors are connected with D1 receptors in such a way that the blockade of the latter results in the functional inactivation of the former.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baggio G, Ferrari F (1983) The role of dopaminergic receptors in the behavioural effects induced by lisuride in male rats. Psychopharmacology 80:38–42

    Google Scholar 

  • Carlson JH, Bergstrom DA, Walters JR (1986) Neurophysiological evidence that D1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. Eur J Pharmacol 23:237–251

    Google Scholar 

  • Christensen AV, Arnt J, Hyttel J, Larsen J-J, Svendsen O (1984) Pharmacological effects of a specific dopamine D1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529–1540

    Google Scholar 

  • Corsini GU, Del Zompo M, Manconi S, Piccardi MP, Onali PL, Manconi A (1977) Evidence for dopamine receptors in the human brain mediating sedation and sleep. Life Sci 20:1613

    Google Scholar 

  • Cross AJ, Mashal RD, Johnson JA, Owen F (1983) Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390. Neuropharmacology 22:1327–1329

    Google Scholar 

  • Di Chiara G, Corsini GU, Mereu G, Tissari A, Gessa GL (1978) Self-inhibitory dopamine receptors: Their role in the biochemical and behavioural effects of low doses os apomoephine. In: Roberts PJ et al. (eds) Advances in biochemical psychopharmacology, vol XIX. Raven, New York, pp 275–292

    Google Scholar 

  • Dubec I, Protais P, Colboc O, Costentin J (1982) Antagonism of the apomorphine-induced yawning by atypical neuroleptics. Neuropharmacology 21:1203

    Google Scholar 

  • Gessa GL, Porceddu ML, Collu M, Serra M, Ongini E, Biggio G (1985) Sedation and sleep induced by high doses of apomorphine after blockade of D1 receptors by SCH 23390. Eur J Pharmacol 109:260

    Google Scholar 

  • Gessa GL, Biggio G, Collu M, Mereu G, Olianas C, Onali P, Ongini E, Porceddu ML, Rossetti ZL, Serra M (1986) SCH 23390: a unique neuroleptic that fails to block dopamine autoreceptors. In: Longo V (ed) Congr Ashkhavad USSR 1986 (in press)

  • Gower AJ, Berendsen HHG, Princen MM, Brokkamp CLE (1984) The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity. Eur J Pharmacol 103:81–89

    Google Scholar 

  • Hyttel J (1983) SCH 23390, the first selective dopamine D1 antagonist. Eur J Pharmacol 91:153–154

    Google Scholar 

  • Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93

    Google Scholar 

  • Laduron PM, Leysen JE (1979) Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28:2161

    Google Scholar 

  • Lehmann J, Briley M, Langer SZ (1983) Characterization of dopamine autoreceptor and 3H-spiperone binding sites in vitro with classical and novel dopamine receptor agonist. Eur J Pharmacol 88:11

    Google Scholar 

  • Mailman RB, Schultz DW, Lewis MH, Staples L, Rollema H, Dehaven DL (1984) SCH 23390: a selective D1 dopamine antagonist with potent D2 behavioural actions. Eur J Pharmacol 101:159–160

    Google Scholar 

  • Mereu G, Collu M, Ongini E, Biggio G, Gessa GL (1985) SCH 23390 a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine. Eur J Pharmacol 111:393–396

    Google Scholar 

  • Mogilnicka E, Klimek V (1977) Drugs affecting dopamine neurons and yawning behaviour. Pharmacol Biochem Behav 7:303

    Google Scholar 

  • Molloy AG, Waddington JL (1984) Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SKF 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82:409–410

    Google Scholar 

  • Nickolson VJ, Berendsen HHG (1980) Effects of potential neuroleptic peptide des-tyrosine γ-endorphin and haloperidol on apomorphine induced behavioural syndromes in rats and mice. Life Sci 27:1377

    Google Scholar 

  • Onali P, Olianas MC, Gessa GL (1984) Selective blockade of dopamine D1 receptors by SCH 23390 discloses striatal dopamine D2 receptors mediating the inhibition of adenylate cyclase in rats. Eur J PHarmacol 99:127–128

    Google Scholar 

  • Pinnock RD (1983) Sensitivity of compacta neurons in the rat substantia nigra slice to dopamine agonists. Eur J Pharmacol 96:269

    Google Scholar 

  • Plantjé JF, Dijcks FA, Verheijden PFHM, Stoof JC (1985) Stimulation of D2 dopamine receptors in rat mesocortical areas inhibits the release of [3H]dopamine. Eur J Pharmacol 114:401–402

    Google Scholar 

  • Porceddu ML, Ongini E, Biggio G (1985) [3H]SCH 23390 binding sites increase after chronic blockade of D1 dopamine receptors. Eur J Pharmacol 118:367–370

    Google Scholar 

  • Protais P, Dubec I, Costentin J (1983) Pharmacological characteristics of dopamine receptors involved in the rat dual effect of dopamine agonists on yawning behaviour in rats. Eur J Pharmacol 94:271

    Google Scholar 

  • Pugh MT, O'Boyle KM, Molloy AG, Waddington JL (1985) Effects of the putative D1 antagonist SCH 23390 on stereotyped behaviour induced by the D2 agonist RU 242213. Psychopharmacology 87:308–312

    Google Scholar 

  • Serra G, Fratta W, Collu M, Napoli-Farris L, Gessa GL (1983a) Cycloheximide prevents apomorphine-induced yawning, penile erection and genital grooming in rats. Eur J Pharmacol 86:279–282

    Google Scholar 

  • Serra G, Collu M, Loddo S, Celasco G, Gessa GL (1983b) Hypophysectomy prevents yawning and penile erection but not hypomotility induced by apomorphine. Pharmacol Biochem Behav 19:917

    Google Scholar 

  • Serra G, Collu M, Vargiu L, Gessa GL (1984a) Possible role of ACTH-MSH peptides in the mediation of apomorphine-induced yawning and penile erection. In: Biggio G, Spano PF, Toffano G and Gessa GL (eds) Advances in the biosciences, Vol 48; Neuromodulation and Brain Function. Pergamon, pp 211–215

    Google Scholar 

  • Serra G, Collu M, Serra A, Gessa GL (1984b) Estrogens antagonize apomorphine-induced yawning in rats. Eur J Pharmacol 104:383

    Google Scholar 

  • Serra G, Collu M, Gessa GL (1986a) Dopamine receptors mediating yawning: are they autoreceptors? Eur J Pharmacol 120:187–192

    Google Scholar 

  • Serra G, Collu M, Gessa GL, Ferrari W (1986b) Melanocortins and dopamine link in yawning behaviour. In: Wied D de, Ferrari W (eds) Central actions of ACTH and related peptides. Springer, Berlin Heidelberg New York Tokyo, pp 163–178

    Google Scholar 

  • Spano PF, Stefanini E, Trabucchi M, Fresia P (1979) Stereospecific interaction of sulpiride with strialtal and nonstriatal dopamine receptors. In: Spano PF, Trabucchi M, Corsini GU and Gessa GL (eds) Sulpiride and other benzamides. Ital Brain Res Foundat Press, Milano, pp 11–21

    Google Scholar 

  • Stähle L, Ungerstedt U (1984) Assessment of dopamine autoreceptor agonist properties of apomorphine, (+)3PPP and (−)3PPP by recording of yawning behaviour in rats. Eur J Pharmacol 98:307–310

    Google Scholar 

  • Stoof JC, Kebabian JW (1981) Opposing roles of D1 and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366–368

    Google Scholar 

  • Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35:2281

    Google Scholar 

  • Walters JR, Bergstrom DA, Carlson JH (1986) Effects of D1 and D2 receptor stimulation on single unit activity in the substantia nigra and globus pallidus. In: GN Woodruff (ed) Dopamine systems and their regulation. MacMillan (in press)

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, University of Cagliari via Porcell 4, I-09100, Cagliari, Italy

    G. Serra, M. Collu & G. L. Gessa

Authors
  1. G. Serra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Collu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. L. Gessa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serra, G., Collu, M. & Gessa, G.L. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390. Psychopharmacology 91, 330–333 (1987). https://doi.org/10.1007/BF00518186

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00518186

Key words

Search

Navigation